How a biotech retailer nearly tripled its monthly organic revenue
The catalog ran to more than 100 products. The pages behind them gave Google, and the scientists buying from them, very little to go on.

The results
Feb 2023 to Mar 2026
- Monthly organic revenue
- $744Kin Mar 2026, from $250K in Jun 2023+197%
- Monthly impressions
- 894,000in Mar 2026, from 106,000 in Apr 2023+744%
- Ranking keywords, US
- 5,488in Jul 2025, from 675 in Feb 2023+713%
- First-page keywords, US
- 470in Q1 2026, from 155 in Feb 2023+203%
- Monthly organic sessions
- 79,900in Mar 2026
- Product pages rebuilt
- 100+the full catalog, with specifications and citations
Revenue and sessions: GA4, organic search. Impressions: Google Search Console, web search. Keywords: Semrush, US. The 2023 baselines are from the monthly reports I sent at the time. Checked 28 Sep 2026.
Contents
The client
A specialized biotech company selling compounds and research materials to scientists, clinicians and research institutions. The catalog runs to more than 100 products.
Their buyers are some of the most technically demanding people online. Researchers don’t browse. They search precisely, read closely and trust sources that meet them at their level. The products were credible, and the website wasn’t showing it.
The problem
Most of the 100-plus product pages were thin: minimal copy, missing metadata, no structured data and none of the technical depth a buyer or a search engine needs to judge them. When purchases turn on specifications and published research, bare product pages are a conversion problem as well as an SEO one.
The site’s structure made it worse. Categories were loosely organized, internal linking was inconsistent, and slow pages were quietly holding rankings down. The foundation needed work before anything else could move.
More than 100 products, and hardly any of them pulling their weight in search.
The strategy
Rebuilding the product pages
I treated every product page as a reference, not a listing. I wrote and optimized copy for the whole catalog, with technical specification tables, research sections backed by academic citations, and prose written for people who read primary literature. I kept the meta tags under review as the catalog changed. A page that earns a researcher’s trust tends to earn Google’s.
Making the site legible to search engines
Good content in a broken structure still underperforms. I added schema markup across the catalog, restructured the product categories, tightened internal linking and fixed the speed problems that were dragging rankings down. None of it is glamorous, and all of it unblocks everything else.
Content for a research audience
The buyer here is a scientist cross-referencing sources before ordering. I built citation-backed content to that standard, so the company reads as a credible supplier in its field rather than one more vendor with a product page. Researchers who find a source they trust come back to it.
Reporting that shows what works
Knowing what works matters as much as the work. I built reporting dashboards across every channel, so the client could see performance clearly and make better decisions as the strategy grew.
The outcome
Monthly organic revenue rose from $250,000 in June 2023, the first month with ecommerce tracking, to $744,000 in March 2026: almost three times as much.
Visibility grew ahead of it. Monthly search impressions went from 106,000 in April 2023 to 894,000 in March 2026. In the US, the number of keywords the site ranked for grew from 675 to 5,488 between February 2023 and July 2025, and first-page keywords from 155 to 470 by early 2026.
The work was methodical by design. Biotech buyers respond to depth, accuracy and trust, not to marketing tactics, and building those across a catalog of more than 100 products takes time. The catalog became a search asset, and each new product now launches onto a structure built to carry it.



